SS Innovations International, Inc.
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Sudhir Prem Srivastava
- Full Time Employees
- 378
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 1600 SE 15th Street Fort Lauderdale FL United States of America 33316
- IPO Date
- Oct 17, 2018
- CIK
- 0001676163
- Website
- ssinnovations.com
- Similar Companies
- Business
- SS Innovations International, Inc. (NASDAQ: SSII) operates as a commercial-stage surgical robotics company that develops, manufactures, and markets advanced, cost-effective robotic systems and related instruments to enable minimally invasive procedures across multiple specialties. Founded in 2015 by Dr. Sudhir Srivastava and headquartered in Gurugram, India, with additional presence in Fort Lauderdale, Florida, the company offers its flagship SSi Mantra surgical robotic system, which supports validated procedures in urology such as radical prostatectomy and nephrectomy; gynecology including hysterectomy and sacrocolpopexy; cardiac surgeries like totally endoscopic coronary artery bypass; thoracic operations such as lobectomy and thymectomy; general surgery encompassing cholecystectomy and hernia repairs; gastrointestinal interventions including esophagectomy and gastrectomy; and head & neck procedures like tonsillectomy; alongside SSi Mudra endosurgical instruments comprising stapling, energy, and core tools including forceps, scissors, electrocautery, and scalpels; accessory products such as sterile drapes, 3D stereo endoscopes, cannulas, and seals; SSi Maya mixed reality training simulator; SSi Yantra multimedia recording and streaming platform; and services including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring. The company sells through direct sales and distributor networks primarily in India and internationally across seven countries with regulatory approvals, targeting hospitals and underserved populations to democratize access to robotic surgery. Recent developments include surpassing 100 SSi Mantra system installations with over 5,000 robotic surgeries performed as of mid-2025; reporting third-quarter 2025 revenue growth driven by 27 system installations, up 350% year-over-year, with nine-month revenue up 123% to $28 million; appointing Naveen Kumar Amar as Chief Financial Officer in September 2025; completing a human factors validation study at Johns Hopkins Hospital in September 2025 ahead of a planned FDA 510(k) submission in Q4 2025; pursuing U.S. and European market entry with De Novo FDA application and CE Mark expected in late 2025; and advancing pipeline technologies such as intraoperative holographic anatomy, telesurgery with 5G, and AI-assisted tools.
UBERDOC Health Technologies Announces Appointment of John Dvor to Board of Directors
SS Innovations Reports First Quarter 2026 Financial Results
SS Innovations Reports First Quarter 2026 Financial Results
SS Innovations Demonstrates Long-Distance Telesurgery Capabilities at Royal Australian College of Surgeons Annual Scientific Congress
SS Innovations Demonstrates Long-Distance Telesurgery Capabilities at Royal Australian College of Surgeons Annual Scientific Congress
SS Innovations Surpasses 10,500 Surgeries Performed with the SSi Mantra Surgical Robotic System
SS Innovations Surpasses 10,500 Surgeries Performed with the SSi Mantra Surgical Robotic System
PRISM MediaWire – Weekly Press Release Round Up – April 20 to April 24, 2026 – Top Financial & Corporate News Highlights
SS Innovations Unveils Cutting-Edge Surgical Robotic Technologies at SMRSC 2026
SS Innovations Unveils Cutting-Edge Surgical Robotic Technologies at SMRSC 2026
SS Innovations to Host SMRSC 2026 in New Delhi, India from April 9-11, 2026
SS Innovations to Host SMRSC 2026 in New Delhi, India from April 9-11, 2026
SS Innovations International (NASDAQ:SSII) & Aterian (NASDAQ:ATER) Critical Contrast
SS Innovations Is A Compelling Surgical Robotics Growth Play
SS Innovations Expands Global Opportunity with Regulatory Approval of the SSi Mantra Surgical Robotic System in Colombia, Oman, Sri Lanka and Kenya
SS Innovations Expands Global Opportunity with Regulatory Approval of the SSi Mantra Surgical Robotic System in Colombia, Oman, Sri Lanka and Kenya
SS Innovations' SSi Mantra Surgical Robotic System Approved for Telesurgeries in Indonesia and the Philippines
SS Innovations' SSi Mantra Surgical Robotic System Approved for Telesurgeries in Indonesia and the Philippines
SS Innovations Reports Fourth Quarter and Full Year 2025 Financial Results
SS Innovations Reports Fourth Quarter and Full Year 2025 Financial Results